The preclinical development of bicalutamide: pharmacodynamics and mechanism of action

This publication has 37 references indexed in Scilit:

• Microheterogeneity of pituitary follicle-stimulating hormone in male rats: differential effects of the chronic androgen deprivation induced by castration or androgen blockade
  Journal of Molecular Endocrinology, 1992
• The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation
  Biochemistry, 1992
• The pharmacokinetics of Casodex in laboratory animals
  Xenobiotica, 1991
• Antiandrogen ICI 176,334 does not prevent development of androgen insensitivity in S115 mouse mammary tumour cells
  Journal of Steroid Biochemistry, 1990
• Studies on the mechanism of action of win 49596: A steroidal androgen receptor antagonist
  The Journal of Steroid Biochemistry and Molecular Biology, 1989
• Endocrine profile of win 49596 in the rat: A novel androgen receptor antagonist
  The Journal of Steroid Biochemistry and Molecular Biology, 1989
• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989
• The effect of ketoconazole related imidazole drugs and antiandrogens on [3H] R1881 binding to the prostatic androgen receptor and [3H]5α-dihydrotestosterone and [3H]cortisol binding to plasma proteins
  The Journal of Steroid Biochemistry and Molecular Biology, 1989
• ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1
  The Lancet, 1896